Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Analysts Have Conflicting Sentiments on These Healthcare Companies: Minerva Neurosciences (NERV) and Verastem (VSTM)
This article highlights analysts’ conflicting sentiments on healthcare companies Minerva Neurosciences (NERV) and Verastem (VSTM). H.C. Wainwright initiated coverage on Verastem with a Buy rating and an $18.00 price target, while RBC Capital also maintained a Buy rating with a $15.00 price target, leading to a Strong Buy consensus for VSTM. The article does not provide specific analyst sentiment for Minerva Neurosciences.